Christopher E. Pollard

604 total citations
13 papers, 453 citations indexed

About

Christopher E. Pollard is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher E. Pollard has authored 13 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher E. Pollard's work include Cardiac electrophysiology and arrhythmias (7 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Christopher E. Pollard is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Christopher E. Pollard collaborates with scholars based in United Kingdom, Sweden and Poland. Christopher E. Pollard's co-authors include Amy Pointon, Najah Abi‐Gerges, Jean‐Pierre Valentin, Helen Garside, Helen Prior, Alexander R. Harmer, Joanne Bowes, Ian L. Dale, Stanley E. Lazic and Stefan Platz and has published in prestigious journals such as Brain Research, European Journal of Pharmacology and Drug Discovery Today.

In The Last Decade

Christopher E. Pollard

13 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Pollard United Kingdom 11 217 164 130 101 60 13 453
David J. Gallacher Belgium 14 348 1.6× 375 2.3× 186 1.4× 117 1.2× 52 0.9× 30 821
Jennifer Pierson United States 14 382 1.8× 476 2.9× 251 1.9× 122 1.2× 71 1.2× 29 782
An N. Hermans Belgium 9 446 2.1× 502 3.1× 126 1.0× 48 0.5× 49 0.8× 12 696
Jean‐Michel Guillon France 11 157 0.7× 184 1.1× 116 0.9× 64 0.6× 22 0.4× 18 371
Payal Rana United States 11 258 1.2× 39 0.2× 59 0.5× 90 0.9× 37 0.6× 26 511
Mark Holbrook United Kingdom 15 262 1.2× 223 1.4× 63 0.5× 18 0.2× 51 0.8× 22 558
Karel Van Ammel Belgium 13 501 2.3× 593 3.6× 151 1.2× 51 0.5× 42 0.7× 26 790
James Kramer United States 7 491 2.3× 549 3.3× 210 1.6× 49 0.5× 63 1.1× 13 741
Rob Towart Belgium 9 360 1.7× 393 2.4× 179 1.4× 61 0.6× 18 0.3× 13 572
Malin K.B. Jonsson Netherlands 16 485 2.2× 329 2.0× 229 1.8× 115 1.1× 11 0.2× 20 695

Countries citing papers authored by Christopher E. Pollard

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Pollard more than expected).

Fields of papers citing papers by Christopher E. Pollard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Pollard. The network helps show where Christopher E. Pollard may publish in the future.

Co-authorship network of co-authors of Christopher E. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Pollard. A scholar is included among the top collaborators of Christopher E. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Pollard. Christopher E. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wiśniowska, Barbara, Mark Holbrook, Christopher E. Pollard, & Sebastian Polak. (2022). Utilization of mechanistic modelling and simulation to analyse fenspiride proarrhythmic potency – Role of physiological and other non‐drug related parameters. Journal of Clinical Pharmacy and Therapeutics. 47(12). 2152–2161. 2 indexed citations
2.
Lazic, Stanley E., Nicholas J. Edmunds, & Christopher E. Pollard. (2017). Predicting Drug Safety and Communicating Risk: Benefits of a Bayesian Approach. Toxicological Sciences. 162(1). 89–98. 17 indexed citations
3.
Pollard, Christopher E., Matthew Skinner, Stanley E. Lazic, et al.. (2017). An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data. Toxicological Sciences. 159(1). 94–101. 42 indexed citations
4.
Pointon, Amy, James Pilling, Thierry Dorval, et al.. (2016). From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery. Toxicological Sciences. 155(2). 444–457. 56 indexed citations
5.
Abi‐Gerges, Najah, et al.. (2016). Assessment of extracellular field potential and Ca2+ transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods. 83. 1–15. 30 indexed citations
6.
Cros, Caroline, et al.. (2015). Enhanced Characterization of Contractility in Cardiomyocytes During Early Drug Safety Assessment. Toxicological Sciences. 145(2). 396–406. 37 indexed citations
7.
Pointon, Amy, Alexander R. Harmer, Ian L. Dale, et al.. (2014). Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicological Sciences. 144(2). 227–237. 81 indexed citations
8.
Roberts, Ruth, Stefan Kavanagh, Howard R. Mellor, et al.. (2013). Reducing attrition in drug development: smart loading preclinical safety assessment. Drug Discovery Today. 19(3). 341–347. 62 indexed citations
9.
Abi‐Gerges, Najah, Amy Pointon, Michael J. Morton, et al.. (2013). Preservation of cardiomyocytes from the adult heart. Journal of Molecular and Cellular Cardiology. 64. 108–119. 25 indexed citations
10.
Redfern, William S., Ian Wakefield, Helen Prior, et al.. (2002). Safety pharmacology – a progressive approach. Fundamental and Clinical Pharmacology. 16(3). 161–173. 48 indexed citations
11.
Pollard, Christopher E.. (1993). A volume-sensitive Cl− conductance in a mouse neuroblastoma × rat dorsal root ganglion cell line (F11). Brain Research. 614(1-2). 178–184. 17 indexed citations
12.
Pollard, Christopher E., et al.. (1992). The effect of nedocromil sodium on the isolated rabbit vagus nerve. European Journal of Pharmacology. 221(1). 175–177. 30 indexed citations
13.
Pollard, Christopher E., et al.. (1990). Spontaneous single cell discharge in rat somatosensory cortical slices and its relationship to discharge in the urethane-anaesthetized rat. Brain Research. 518(1-2). 120–126. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026